262 related articles for article (PubMed ID: 4278087)
1. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
Post RM; Goodwin FK
Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
[No Abstract] [Full Text] [Related]
2. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.
Goodwin FK; Post RM; Dunner DL; Gordon EK
Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466
[No Abstract] [Full Text] [Related]
3. Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes.
Bowers MB
J Nerv Ment Dis; 1974 May; 158(5):325-30. PubMed ID: 4823933
[No Abstract] [Full Text] [Related]
4. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
Garelis E; Young SN; Lal S; Sourkes TL
Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
[No Abstract] [Full Text] [Related]
5. Brain serotonin, affective illness, and antidepressant drugs: cerebrospinal fluid studies with probenecid.
Goodwin FK; Post RM
Adv Biochem Psychopharmacol; 1974; 11(0):341-55. PubMed ID: 4276863
[No Abstract] [Full Text] [Related]
6. 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment.
Sjöström R
Eur J Clin Pharmacol; 1973 Aug; 6(2):75-80. PubMed ID: 4588853
[No Abstract] [Full Text] [Related]
7. Effect of ECT and imipramine treatment on the concentration of 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) in the cerebrospinal fluid of depressed patients.
Jori A; Dolfini E; Casati C; Argenta G
Psychopharmacologia; 1975 Oct; 44(1):87-90. PubMed ID: 1105628
[TBL] [Abstract][Full Text] [Related]
8. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
Bowers MB; Heninger GR
Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
[No Abstract] [Full Text] [Related]
9. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
Andersson H; von Essen C; Roos BE
Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033
[No Abstract] [Full Text] [Related]
10. Cerebrospinal fluid probenecid studies: a reinterpretation.
Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
[TBL] [Abstract][Full Text] [Related]
11. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
Bowers MB
Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448
[No Abstract] [Full Text] [Related]
12. 5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis.
Sjöström R; Roos BE
Eur J Clin Pharmacol; 1972 Jun; 4(3):170-6. PubMed ID: 4655292
[No Abstract] [Full Text] [Related]
13. Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients.
Mendels J; Frazer A; Fitzgerald RG; Ramsey TA; Stokes JW
Science; 1972 Mar; 175(4028):1380-2. PubMed ID: 5059569
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.
Korf J; van Praag HM; Schut D; Nienhuis RJ; Lakke JP
Eur Neurol; 1974; 12(5-6):340-50. PubMed ID: 4448192
[No Abstract] [Full Text] [Related]
15. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
[No Abstract] [Full Text] [Related]
16. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
Abrams R; Essman WB; Taylor MA; Fink M
Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078
[TBL] [Abstract][Full Text] [Related]
17. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate].
Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G
Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166
[No Abstract] [Full Text] [Related]
18. Probenecid: dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit.
Muizelaar JP; Oberink JI
Psychopharmacologia; 1975 Sep; 43(3):223-7. PubMed ID: 1187954
[TBL] [Abstract][Full Text] [Related]
19. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
Gumpert J; Sharpe D; Curzon G
J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
[No Abstract] [Full Text] [Related]
20. Influence of convulsive therapy on 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in endogenous depression.
Nordin G; Ottosson JO; Roos BE
Psychopharmacologia; 1971; 20(4):315-20. PubMed ID: 5561655
[No Abstract] [Full Text] [Related]
[Next] [New Search]
